Paper39313657
Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway.
Arthur R and 2 others. Mol Neurobiol, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway. Papers, record 39313657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39313657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nitro Compounds | Major topic |
| Propionates | Major topic |
| NF-E2-Related Factor 2 | Major topic |
| Artemisinins | Major topic |
| Brain-Derived Neurotrophic Factor | Major topic |
| Signal Transduction | Major topic |
| MAP Kinase Signaling System | Major topic |
| Animals | |
| Male | |
| Humans | |
| Cell Line, Tumor | |
| Neuroprotective Agents | |
| Oxidative Stress | |
| Rats | |
| Apoptosis | |
| Heme Oxygenase-1 | |
| Rats, Sprague-Dawley |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24316259 | Artemisinins: pharmacological actions beyond anti-malarial. | Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24316259 | PubMed |
| 2 | 28852397 | Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. | Neural Regen Res | 2017 | https://conductscience.org/library/papers/28852397 | PubMed |
| 3 | 35683033 | Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35683033 | PubMed |
| 4 | 35639233 | Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway. | Inflammopharmacology | 2022 | https://conductscience.org/library/papers/35639233 | PubMed |
| 5 | 31728850 | Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model. | Neurotherapeutics | 2020 | https://conductscience.org/library/papers/31728850 | PubMed |
| 6 | 36932199 | Neuromodulatory effect of 4-(methylthio)butyl isothiocyanate against 3-nitropropionic acid induced oxidative impairments in human dopaminergic SH-SY5Y cells via BDNF/CREB/TrkB pathway. | Sci Rep | 2023 | https://conductscience.org/library/papers/36932199 | PubMed |
| 7 | 32765947 | Artemisinin Improved Neuronal Functions in Alzheimer's Disease Animal Model 3xtg Mice and Neuronal Cells via Stimulating the ERK/CREB Signaling Pathway. | Aging Dis | 2020 | https://conductscience.org/library/papers/32765947 | PubMed |
| 8 | 31288090 | Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. | Mitochondrion | 2019 | https://conductscience.org/library/papers/31288090 | PubMed |
| 9 | 35615642 | Current and Possible Future Therapeutic Options for Huntington's Disease. | J Cent Nerv Syst Dis | 2022 | https://conductscience.org/library/papers/35615642 | PubMed |
| 10 | 24723322 | The 3-NP Model of Striatal Neurodegeneration. | Curr Protoc Neurosci | 2014 | https://conductscience.org/library/papers/24723322 | PubMed |
| 11 | 36359390 | Beta-Boswellic Acid Reverses 3-Nitropropionic Acid-Induced Molecular, Mitochondrial, and Histopathological Defects in Experimental Rat Model of Huntington's Disease. | Biomedicines | 2022 | https://conductscience.org/library/papers/36359390 | PubMed |
| 12 | 27188817 | Huntington disease. | Nat Rev Dis Primers | 2015 | https://conductscience.org/library/papers/27188817 | PubMed |
| 14 | 31234550 | The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31234550 | PubMed |
| 15 | 31063707 | Neuroprotective offerings by agmatine. | Neurotoxicology | 2019 | https://conductscience.org/library/papers/31063707 | PubMed |
| 16 | 35472453 | Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway. | Life Sci | 2022 | https://conductscience.org/library/papers/35472453 | PubMed |
| 17 | 30399421 | Artemisinin B Improves Learning and Memory Impairment in AD Dementia Mice by Suppressing Neuroinflammation. | Neuroscience | 2018 | https://conductscience.org/library/papers/30399421 | PubMed |
| 18 | 28118852 | The SH-SY5Y cell line in Parkinson's disease research: a systematic review. | Mol Neurodegener | 2017 | https://conductscience.org/library/papers/28118852 | PubMed |
| 19 | 34099897 | Molecular mechanisms of cell death in neurological diseases. | Cell Death Differ | 2021 | https://conductscience.org/library/papers/34099897 | PubMed |
| 20 | 37548586 | Electroacupuncture ameliorates pain in cervical spondylotic radiculopathy rat by inhibiting the CaMKII/CREB/BDNF signaling pathway and regulating spinal synaptic plasticity. | Brain Behav | 2023 | https://conductscience.org/library/papers/37548586 | PubMed |
| 21 | 32020857 | Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo. | BMC Complement Med Ther | 2020 | https://conductscience.org/library/papers/32020857 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42955301 | Trigonelline attenuates thioacetamide-induced nephrotoxicity through modulation of KIM-1/NGAL expression, and suppression of oxidative stress, renal apoptosis, inflammation, and fibrosis. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42955301 | PubMed |
| 42464718 | Silymarin Modulates 3-Nitropropionic Acid-Induced Oxidative Neurotoxicity and Apoptosis Through the Inhibition of TRPV1 Channel in Mouse Brain and Hippocampal Neurons. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42464718 | PubMed |
| 42196584 | Research Progress on Anti-Inflammatory and Antioxidant Mechanism of Artemether Based on MAPK/NF-κB Signaling Pathway. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196584 | PubMed |
| 42007147 | Gypenosides attenuate H2O2-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42007147 | PubMed |
| 41531728 | HMOX1 drives dihydroartemisinin-sensitized ferroptosis antagonized by mitochondrial fusion. | iScience | 2026 | https://conductscience.org/library/papers/41531728 | PubMed |
| 41249612 | Targeting neuroinflammatory pathways in epilepsy: a combined network-pharmacology and in vivo study of dapagliflozin and ticagrelor. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41249612 | PubMed |
| 40427418 | A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40427418 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BDNF | 627 | PubTator's text mining | https://conductscience.org/library/genes/627 | NCBI Gene |
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 | NCBI Gene |
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39313657
GET https://conductscience.org/api/papers/v1/39313657/references?page=2